Highlights Novavax, Inc.

Equities

NVAX

US6700024010

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 01:52:21 2026-03-16 pm EDT			5-day change	1st Jan Change
10.08 ^USD	-1.47%		-4.27%	+50.30%

Mar. 10	Novavax, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 03:40 PM
Mar. 03	Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM

Highlights

Feb. 26	Novavax raises revenue forecast on boost from vaccine deals, shares soar	RE
Feb. 26	Novavax outlook 2026 adjusted total revenue $230 mln - $270 mln	RE
Feb. 26	Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals	RE
Feb. 26	Top Midday Gainers	MT
Feb. 26	Novavax, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
Feb. 26	Novavax Shares Jump After Swinging to Profit in Q4	MT
Feb. 26	Novavax raises revenue forecast on boost from vaccine deals, shares soar	RE
Feb. 26	Earnings Flash (NVAX) Novavax Posts Q4 Total Revenue $147.1M, vs. FactSet Est of $89.8M	MT
Feb. 26	Earnings Flash (NVAX) Novavax Posts Q4 EPS $0.11, vs. FactSet Est of $0.48 Loss	MT
Jan. 20	Novavax, Inc. Enters into A License and Option Agreement with Pfizer Inc	CI
Jan. 20	Novavax Enters Non-Exclusive Licensing Deal With Pfizer	MT
Nov. 12	Shah Capital pushes for Novavax sale	RE
Nov. 12	Shah Capital pushes for Novavax sale, warns of proxy fight	RE
Nov. 12	Shah Capital Urges Novavax Board to Address Operational Inefficiencies and Consider Strategic Merger to Maximize Vaccine Potential	CI
Nov. 06	Novavax delays profitability target with eyes on Sanofi-led launches	RE
Nov. 06	Novavax, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 06	Novavax Stock Edges Higher After 2025 Adjusted Revenue Forecast Raised	MT
Nov. 06	Earnings Flash (NVAX) Novavax, Inc. Reports Q3 Revenue $70.4M, vs. FactSet Est of $42.1M	MT
Nov. 06	Earnings Flash (NVAX) Novavax Posts Q3 Net Loss $1.25 a Share, vs. FactSet Est of $1.20 Loss	MT
Nov. 06	Novavax beats quarterly revenue estimates on milestone payment	RE
Nov. 06	Novavax defers profitability target by a year on weak COVID vaccine sales	RE
Nov. 04	Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid	CI
Nov. 04	Novavax Completes Nuvaxovid US Marketing Authorization Transfer to Sanofi	MT
Nov. 04	Novavax - FDA approves transfer of Nuvaxovid authorization to Sanofi - SEC filing	RE
25-10-22	Waiting for Elon